Gene: FLRT3
Official Full Name: fibronectin leucine rich transmembrane protein 3provided by HGNC
Gene Summary: This gene encodes a member of the fibronectin leucine rich transmembrane protein (FLRT) family. FLRTs may function in cell adhesion and/or receptor signalling. Their protein structures resemble small leucine-rich proteoglycans found in the extracellular matrix. This gene is expressed in many tissues. Two alternatively spliced transcript variants encoding the same protein have been described for this gene. [provided by RefSeq, Jul 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28978 | FLRT3 Knockout cell line (HEK293) | Human | FLRT3 | 1:3~1:6 | Negative | Online Inquiry |
KO28979 | FLRT3 Knockout cell line (A549) | Human | FLRT3 | 1:3~1:4 | Negative | Online Inquiry |
FLRT3 Gene Knockout Cell Lines are genetically engineered cell lines in which the FLRT3 gene has been inactivated, enabling researchers to study the biological roles and functions of this specific gene. FLRT3, or Fibronectin Leucine-rich Repeat Transmembrane Protein 3, is involved in essential cellular processes, including cell adhesion, migration, and signaling pathways critical for the development of the nervous system. These knockout cell lines are invaluable tools for elucidating the mechanistic pathways regulated by FLRT3 and for identifying potential therapeutic interventions.
The fundamental mechanism of these cell lines revolves around the traditional gene editing technology, which utilizes CRISPR/Cas9 or other gene-editing techniques to create a null mutation in the FLRT3 gene. This alteration allows for direct observation of both the loss-of-function consequences and the compensatory mechanisms that may occur in cellular behavior. Researchers can utilize these cell lines to investigate FLRT3’s role in various processes such as neuronal differentiation, synaptogenesis, and its implication in neurological disorders.
In terms of scientific importance, FLRT3 Gene Knockout Cell Lines have broad applications ranging from basic biological research to translational medicine. They facilitate comprehensive studies on cellular processes tied to neural development and disease, and potentially aid in the discovery of novel targets for drug development that may mitigate conditions like schizophrenia and autism spectrum disorders.
What sets these knockout cell lines apart from standard cell culture systems is the precision in gene targeting that allows for highly reproducible results, reducing variability often associated with secondary consequences following partial gene knockdowns. Additionally, they provide a robust platform for complementing high-throughput screening efforts in pharmacological studies and elucidating gene function further than what traditional models would permit.
For researchers and clinicians aiming to decode the biological intricacies of FLRT3, these knockout cell lines represent a pivotal resource. They not only foster greater insights into gene function but also pave the way for improved therapeutic strategies. Our company, with its dedication to cutting-edge genetic engineering and molecular biology, supplies this product with the assurance of high quality and scientific rigor, underscoring our commitment to advancing research across biological disciplines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.